Key result
Electrical cardioversion outperforms most pharmacotherapies in efficacy and safety for atrial flutter.
Why the study?
Does electrical cardioversion improve efficacy and safety compared to pharmacological management in patients with atrial flutter?
Does electrical cardioversion improve efficacy and safety compared to pharmacological management in patients with atrial flutter?
Electrical cardioversion is generally superior to pharmacological management in terms of efficacy and safety for patients with atrial flutter.
May support electrical cardioversion preference for atrial flutter; leaves open individualized decisions in specific contexts.
Evidence shows that electrical cardioversion is highly effective for atrial flutter, with superiority over most pharmacological management in terms of efficacy and safety, except in specific contexts or patient preferences.
No takes yet. Share an insight, caveat, or question.
Tripdatabase (2026) studied this question. Electrical cardioversion demonstrates superiority over most pharmacological management in efficacy and safety for treating atrial flutter.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: